| scholarly article | Q13442814 |
| P50 | author | Wen Cai Zhang | Q57002624 |
| He Huang | Q90172843 | ||
| Carol J Bult | Q91498166 | ||
| P2093 | author name string | John M Asara | |
| Min Yuan | |||
| Frank J Slack | |||
| Katerina Politi | |||
| Daniel B Costa | |||
| Mary Ann Melnick | |||
| Tanvi Saxena | |||
| Kin-Hoe Chow | |||
| Julie M Wells | |||
| P2860 | cites work | Ultrafast and memory-efficient alignment of short DNA sequences to the human genome | Q21183894 |
| KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib | Q21563446 | ||
| HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing | Q24291102 | ||
| Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha | Q24338422 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| A scaling normalization method for differential expression analysis of RNA-seq data | Q24628783 | ||
| Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells | Q24683296 | ||
| Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain | Q24794765 | ||
| Fundamentals of cancer metabolism | Q26744062 | ||
| Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? | Q26852282 | ||
| HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression | Q27025886 | ||
| EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 | ||
| EGFR mutation and resistance of non-small-cell lung cancer to gefitinib | Q27824829 | ||
| Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M. | Q27853162 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
| Oncometabolites: tailoring our genes | Q28085392 | ||
| Molecular basis of the VHL hereditary cancer syndrome | Q28220414 | ||
| Comprehensive molecular profiling of lung adenocarcinoma | Q28244995 | ||
| Fgf10 is essential for limb and lung formation | Q28295033 | ||
| Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase | Q28302589 | ||
| Noggin | Q28303836 | ||
| Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging | Q28304473 | ||
| MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance | Q28538690 | ||
| In vitro generation of human pluripotent stem cell derived lung organoids | Q28973622 | ||
| A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations | Q29614275 | ||
| Differential analysis of gene regulation at transcript resolution with RNA-seq | Q29614490 | ||
| A ROCK inhibitor permits survival of dissociated human embryonic stem cells | Q29616183 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| A novel normalization method for effective removal of systematic variation in microarray data | Q31033962 | ||
| Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis | Q31127142 | ||
| STUDIES ON SUCCINATE DEHYDROGENASE. I. SPECTRAL PROPERTIES OF THE PURIFIED ENZYME AND FORMATION OF ENZYME-COMPETITIVE INHIBITOR COMPLEXES | Q33971857 | ||
| FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway. | Q34007808 | ||
| Primary tumor genotype is an important determinant in identification of lung cancer propagating cells | Q34015722 | ||
| Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. | Q34032640 | ||
| Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells | Q34752692 | ||
| Human cancer growth and therapy in immunodeficient mouse models | Q35545282 | ||
| Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients | Q36475779 | ||
| Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation | Q36477750 | ||
| Metabolic Heterogeneity in Human Lung Tumors. | Q36578111 | ||
| Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells | Q36605057 | ||
| Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy | Q36698266 | ||
| A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue | Q36937203 | ||
| Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition | Q36989342 | ||
| Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. | Q37034545 | ||
| Heatmapper: web-enabled heat mapping for all | Q37182163 | ||
| The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer | Q37299263 | ||
| Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer | Q37421439 | ||
| pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner | Q37666827 | ||
| An ID2-dependent mechanism for VHL inactivation in cancer | Q37741948 | ||
| A comprehensive transcriptional portrait of human cancer cell lines | Q37854720 | ||
| Revisiting the TCA cycle: signaling to tumor formation | Q37901922 | ||
| Targeting noncoding RNAs in disease | Q38752040 | ||
| MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells | Q38839282 | ||
| MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Q39139786 | ||
| Glycine decarboxylase is an unusual amino acid decarboxylase involved in tumorigenesis. | Q39263236 | ||
| Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. | Q39416388 | ||
| miR-181a and miR-630 regulate cisplatin-induced cancer cell death | Q39741509 | ||
| Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase. | Q40431257 | ||
| Immortalization and transformation of primary human airway epithelial cells by gene transfer. | Q40722115 | ||
| Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation | Q41468666 | ||
| ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays | Q43536416 | ||
| Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance | Q45347095 | ||
| Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. | Q46265031 | ||
| Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages | Q46485595 | ||
| NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis | Q47371292 | ||
| Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer | Q47450132 | ||
| The Mouse Tumor Biology Database: A Comprehensive Resource for Mouse Models of Human Cancer. | Q47564965 | ||
| Maternally Expressed Gene 3 (MEG3) Enhances PC12 Cell Hypoxia Injury by Targeting MiR-147. | Q47713931 | ||
| Wnt signaling in cancer. | Q51518956 | ||
| ADARs Edit MicroRNAs to Promote Leukemic Stem Cell Activity. | Q51592521 | ||
| MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells | Q52642914 | ||
| Mitochondria and Cancer | Q53198693 | ||
| PDGF-A Signaling Is a Critical Event in Lung Alveolar Myofibroblast Development and Alveogenesis | Q57415025 | ||
| Deep RNA Sequencing Reveals a Repertoire of Human Fibroblast Circular RNAs Associated with Cellular Responses to Herpes Simplex Virus 1 Infection | Q59357632 | ||
| A critical role for fibroblast growth factor-7 during early alveolar formation in the neonatal rat | Q80227606 | ||
| pVHL: a multipurpose adaptor protein | Q81470388 | ||
| Pyrosequencing enhancement for better detection limit and sequencing homopolymers | Q85015915 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 460-474 | |
| P577 | publication date | 2019-04-08 | |
| P1476 | title | miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma | |
| P478 | volume | 1 |
| Q89730770 | A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells |
| Q97643957 | Mir-roring hypoxia in EGFR-TKI tolerance |
| Q94960300 | Spatially resolved and multiplexed MicroRNA quantification from tissue using nanoliter well arrays |
| Q91807615 | microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance |
| Q90380026 | ncRNAs: New Players in Mitochondrial Health and Disease? |
Search more.